JM-2820

N/A

Report date: 2024/12/04 11:16:00

Base Information

Drug NameJM-2820
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnormed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvid Corp
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A